YELOID CELLS, including granulocytes and mono-M cytes, convert arachidonic acid to leukotrienes (LT) via the 5-lipoxygenase pathway.' LTB4 potently promotes physiologic, inflammatory events, such as adhesion to the vessel wall, chemotaxis, and degranulation of granulocytes. The cysteinyl leukotrienes LTC4, LTD,, and LTE4 induce plasma leakage and are important asthma mediators, inducing smooth muscle contraction, increased microvascular permeability, and mucus secretion.' In addition, a number of reports during recent years have indicated that the LTs also possess modulatory effects on cell proliferation. Both LTBI and LTC4 have been demonstrated to increase the in vitro growth of arterial smooth muscle cells,* airway epithelial cells,3 and mitogen-stimulated lymphocyte^.^ In cultures of human bone marrow (BM) cells, the effect of LTs has appeared less consistent. Thus, in an early report, LTB4 was claimed to stimulate the formation of myeloid colonie~.~ Furthermore, a similar role was suggested for LTC4, because this compound reversed the suppression of colony formation induced by lipoxygenase inhibitors6 However, these results were disputed by others who proposed inhibitory effects of both LTB, and LTC4.' In the present study, we have therefore reinvestigated the role of LTs in human myelopoiesis using normal human mononuclear BM cells stimulated with a suboptimal concentration of recombinant granulocyte-macrophage colony-stimulating factor (GM-CSF). Chemistry, Karolinska Institutet; and the Hematology Laboratory, Karolinska Hospital, Stockholm, Sweden. Submitted April 28, 1992; accepted September 14, 1992 
MATERIALS AND METHODS
Reagents. LTB4, LTC4, LTDI, and LTE4 were kind gifts from Dr T. Miyamoto (ONO Company, Osaka, Japan). Biosynthetic 5(S), I2(S)-dihydroxyeicosatetraenoic acid [5(S), I2(S)-diHETE] was prepared as described. 8 The identities of the compounds were routinely checked by UV-spectroscopy and high performance liquid chromatography (HPLC). The sulfasalazine analogue CL42A [5'-(2,4-dich1orobenzoyl)T-hydroxyphenyl-acetic acid] and the LTD4 antagonist IC1 1986 15 were generously supplied by Pharmacia AB (Uppsala, Sweden) and Imperial Chemical Industries PLC (Cheshire, UK), respectively. Ficoll-Hypaque was purchased from Pharmacia Fine Chemicals (Uppsala, Sweden) and Escherichia coli-derived recombinant human GM-CSF from Amersham Intemational (Amersham, UK). GIBCO (Paisley, UK) supplied fetal calf serum (FCS), Iscove's medium (Dulbecco's formulation), and phosphate-buffered saline (PBS; Dulbecco's formulation, 0.9 mmol calcium/L, pH 7.4). BactoAgar was from Difco Laboratories (Detroit, MI).
Human BM cells from 3 I healthy, medicinefree volunteers were collected into heparinized tubes (50 U/mL) by needle aspiration from the iliac crest. Informed consent was obtained from each individual and the project was approved by the Ethical Committee of Karolinska Institutet. Mononuclear cells were isolated by separation on a Ficoll-Hypaque gradient. After centrifugation at 400g for 30 minutes, cells in the interphase layer were collected and washed three times in PBS. Staining with Turk's solution demonstrated a cell population with more than 97% mononuclear cells. The viability of these cells was more than 95% as judged by the trypan blue exclusion test.
Colony assay. The mononuclear BM cells were resuspended in a mixture of Iscove's medium with 10% FCS and 0.3% agar. Onemilliliter portions of the cell suspensions, containing 0.2 X IO6 cells, were placed in Petri dishes on top of a I-mL feeder layer. The feeder contained 0.5% agar in Iscove's medium and recombinant human GM-CSF. Dose-response curves from preliminary experiments demonstrated an optimal progenitor cell growth in the presence of 25 U (equivalent to 0.5 ng) GM-CSF per dish. Suboptimal concentrations ofGM-CSF (12.5 U per dish) were used in the experiments to facilitate the estimation of modulatory effects exerted by added substances. Various concentrations of LTs and other specified compounds were added from stock solutions in ethanol to the cell layers during plating. The final ethanol concentration in the dishes never exceeded 0.0570, a concentration that by itself did not affect colony growth. All cultures were incubated for 10 days at 37°C in a cell incubator with an automatically regulated fully humidified atmosphere of 5% CO2 in air. Control dishes were made in sets of six and all other dishes in triplicates. The dishes were code-numbered and scored blindly directly after the IO-day cultivation using an inverted microscope (Zeiss, ObCell preparations. In the experiments reported below, the suboptimal GM-CSF concentration (12.5 U per dish) was used in all culture dishes. Efects of LTs and 5(S),I2(S)-diHETE on GM-CSF-induced BM colony formation. LTC, provoked a dose-dependent increase in GM-CSF-induced myeloid progenitor cell growth (Fig I) . Maximal effect was observed at IO-' mol/ L LTC,, which stimulated the colony formation in 8 of 9
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tested BMs, with a mean increase of 91% ? 23% (P = .004).
The highest individual increase observed was 222%. Addition of IO-" mol/L LTC, stimulated the growth in 22 of 26 tested BMs, with a mean increase of 38% f 9% (P = .0003), whereas the corresponding result for mol/L LTC, was stimulation in 7 of 9 marrows, with a mean increase of 32% f 9% (P = .006). In contrast, the highest and lowest concentrations of LTC, ( and IO-', mol/L) failed to induce significant stimulation (Fig 1) . The stimulatory capacity of the related cysteinyl leukotrienes LTD, and LTE, (IO-'* to lo-* mol/ L) did not equal that of LTC,. Thus, LTD, produced a significant, but moderate stimulation at IO-'' mol/L (17% f 7%; P = .034), whereas all other concentrations of LTD4
or LTE, failed to consistently influence colony formation (Table I) . Addition of LTB, to GM-CSF-stimulated BM cultures also resulted in elevated colony formation (Fig 2) . The strongest effect was observed with lo-' mol LTB4/L, which enhanced the number of colonies in 9 of IO BMs, with a maximal increase of 164% and a mean increase of 73% f 22% (P = .008). The stimulatory capacity of LTB, was significant also at lower concentrations, with 25% ? 1 1% (P = .033) and For
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46% k 20% (P = .047) increases at lo-'' mol/L and lo-'* mol/L, respectively. In contrast, addition of mol LTB,/ L was without consistent effect.
In parallel experiments, LTB4 was replaced by the double dioxygenation product 5(S), 12(S)-diHETE, an LTB, isomer. As demonstrated in Fig 2, no effect on the colony formation could be observed after addition of 5(S),l2(S)-diHETE to IO-* mol/L).
There was no correlation between the stimulatory effects of the LTs and the number of colonies in control dishes.
Effects of CL42A and ICI 198615 on BM colony formation. The sulfasalazine analogue CL42A was added to BM cultures either alone or in combination with LTB, or LTC,. Addition of 10 pmol CL42A/L decreased the colony formation in 4 of 4 tested marrows (mean, 3 1 % f 10% inhibition; P = .05), whereas the presence of 50 pmol CL42A/L totally abolished the growth in all 3 tested BMs (P < .001). The moderate growth inhibition induced by 10 pmol CL42AIL was completely reversed by increasing concentrations of either LTB4 or LTC, (Fig 3A) . Furthermore, either of these LTs could also partly restore the pronounced growth inhibition provoked by 50 pmol CL42A/L (Fig 3B) .
The effect of the LTD, receptor antagonist IC1 198615 ( lo-' mol/L) on progenitor cell proliferation was investigated in BM cultures from six donors (Fig 4) . When added alone, IC1 198615 did not alter GM-CSF-induced growth. Moreover, the parallel addition of IC1 1986 15 to cultures stimulated with LTC, (lo-'' mol/L) did not significantly counteract the stimulatory effect exerted by this LT. circulating leukocytes, but also by BM cells.' It was therefore of interest to elucidate whether the LTs, which are potent regulators of leukocyte function, could also participate in the regulation of leukocyte formation. By investigating the effect of LTs on BM specimens from a large number of healthy individuals, we could clearly demonstrate that both LTB, and LTC, enhanced the proliferation of myeloid progenitor cells in vitro. This stimulatory action required the presence ofthe growth factor GM-CSF, a substance known to be crucial for the maintenance of normal human myelopoiesis." The enhanced colony formation was observed already at picomolar concentrations of LTC, or LTB,, with maximal effect of both compounds at lo-' mol/L. Within this concentration range, these LTs induce a number of biologic events, such as LTB,-mediated neutrophil chemotaxis and LTC,-induced constriction of human bronchi. ' A limited number of studies have previously addressed the question of whether LTs can influence human myelopoiesis. However, the published results have been contradictive. Thus, an initial study reported that addition of LTB4 to growth factor-stimulated human BM cells induced a significant but moderate increase in the colony f~rmation.~ Another report disputed these results and stated that neither LTB, nor LTC, or LTD4 could potentiate the growth when added alone to human myeloid progenitor cells in the presence of colonystimulating factors6 However, these investigators also showed that nordihydroguaiaretic acid (NDGA), a dual lipoxygenase and prostaglandin endoperoxide synthase inhibitor, strongly reduced colony formation and that LTC, and LTD,, but not LTB,, could reverse this inhibition. 6 The opposite effects, ie, promotion of myeloid stem cell growth by NDGA and inhibition by LTB4 or LTC, (IO-' to mol/L), were later reported.' The obviously discrepant conclusions of the various For personal use only. on October 22, 2017. by guest www.bloodjournal.org From studies may be explained by several factors. First, various types and concentrations of colony-stimulating factors, as well as different incubation techniques, were used. Second, different and sometimes unphysiologically high concentrations of LTs were used. Third, the use of the colony formation assay involves elements of subjectivity in the scoring procedure as well as a considerable interindividual sampling variation. Therefore, it is advisable both to use a blinded scoring system and to examine a sufficient number of BMs. Notably, some of the proposed conclusions above were based on only two or three experiments. In the present study, using a large number of BMs, we have accumulated data that clearly support a stimulatory role for LTC4 and LTB4 in human myelopoiesis. The investigation was facilitated by the use of a suboptimal concentration of recombinant human GM-CSF, which optimized the modulatory effects exerted by the tested compounds.
Among the cysteinyl LTs, LTC4 was by far the most effective stimulator of myeloid progenitor cell growth, whereas LTD, possessed less activity and LTE4 was without significant effect. This is in good agreement with the mitogenic effects of these compounds in human airway epithelial cells. 3 The results suggest that human myelopoiesis is modulated via events depending on the binding of agonist to receptors specific for LTC4 on myeloid progenitors or regulatory cells in the microenvironment. This was also indicated by the inability of the specific LTD,-antagonist IC1 1986 15 to reverse the stimulatory effect of LTC, . While compelling evidence supports the existence of a specific LTD, receptor, the presence of a distinct LTC, receptor has been questioned.'' However, a receptor predominantly activated by LTC, and insensitive to LTD4-antagonists has been described in the guinea pig ileum.'* In agreement, a receptor with the same specificity was recently also discovered in human vascular tissue (Dr S.-E. Dahltn, Karolinska Institutet, personal communication, April 1992). The true nature of the receptor involved in LTC,-induced stimulation of human myelopoiesis needs to be further elucidated.
Proliferation of human myeloid progenitor cells was also stimulated by LTB4 with a potency similar to that of LTC,. In contrast, the LTB,-isomer 5(S), 12(S)-diHETE was without effect. This is in agreement with a previous report in which 5(S), 12(S)-diHETE was also suggested to antagonize the positive effect of LTB4. 5 The results indicate a structural specificity of the LTB4-induced stimulation and suggest involvement of a specific LTB4 receptor in the signal transduction process.
The dual 5-lipoxygenase and prostaglandin endoperoxide synthase inhibitor CL42AI3 suppressed myelopoiesis when added in the absence of exogenous LTs. This was most probably due to attenuation of the endogenous LT formation, because earlier reports have demonstrated that the myelopoiesis is unaffected by inhibition of the prostaglandin endoperoxide synthase.14 The results indicate a modulatory role for endogenously formed LTs in myeloid progenitor cell growth. Furthermore, the inhibitory action of CL42A was efficiently reversed by both LTB4 and LTC4. The finding that the LTs stimulated myelopoiesis also in the presence of CL42A excludes the possibility that the mitogenic effect on human myeloid BM cells was mediated via formation of prostaglandin endoperoxide synthase products, as has earlier been reported for LTB4 in rat smooth muscle cells. '5 In addition to the LTs, other bioactive lipoxygenase products may also participate in the modulation of human myelopoiesis. Thus, we have recently demonstrated lipoxin (LX) formation from endogenous substrate in normal BM.I6 In addition, subnanomolar concentrations of both LXA4 and LXB, stimulated GM-CSF-induced colony formation. At higher concentrations, LXA,, but not LXB4, could also reverse LTC4-induced stimulation of colony growth. A similar dual role of LXA4 has previously been indicated in other systems. Thus, this LX was demonstrated to stimulate neutrophil migration," whereas preincubation of human polymorphonuclear granulocytes with LXA4 dose-dependently inhibited LTB4-induced chemotaxis.'* A pathophysiologic role for LTs, and possibly also for LXs, may be proposed in chronic myelogenous leukemia (CML). Consequently, the capacity of white blood cells from CML patients to synthesize LTC, was significantly increased." In contrast, CML platelets possessed a markedly decreased capacity to participate in the transcellular synthesis of the potential myelopoiesis inhibitors LXA4 and 5(S), 12(S)-di-HETE." Moreover, the production of these compounds was totally abolished in platelets obtained from CML patients in blastic crisis. This pathologically altered formation of lipoxygenase products may thus contribute to the strongly enhanced proliferation of myeloid cells in CML.
The mechanisms by which LTs and LXs modulate myelopoiesis are essentially unknown. However, stimulation of progenitor cell growth induced by these compounds required the presence of GM-CSF. Furthermore, GM-CSF-induced stem cell growth was suppressed when the production of LTs and LXs was prevented by CL42A. These results suggest sophisticated interactions between GM-CSF and the lipoxygenase products. Recent studies on hematopoiesis have demonstrated a complicated interplay between progenitor cells and other surrounding hematologic and nonhematologic cells. These interactions are mediated via the release of GM-CSF and other cytokines." In the light of the present findings it is therefore of interest that priming with GM-CSF has been demonstrated to enhance LT synthesis in purified granulocyte suspensions and LX synthesis in platelet/granulocyte mixture~."-'~ In addition, cytopenic patients treated with this growth factor showed an increased urinary excretion of cysteinyl LTs.*~ Future studies using fractionated, well-defined cell populations and controlled growth conditions are needed to further clarify the precise role of lipoxygenase products in myelopoiesis.
